SRC tyrosine kinase activity in osteolysis associated with metastatic human breast cancer.

被引：0
|
作者：
Myoui, A [1 ]
Nishimura, R [1 ]
Michigami, T [1 ]
Williams, P [1 ]
Dallas, M [1 ]
Mundy, GR [1 ]
Yoneda, T [1 ]
机构：
[1] UNIV TEXAS,HLTH SCI CTR,SAN ANTONIO,TX 78284
来源：
JOURNAL OF BONE AND MINERAL RESEARCH | 1996年 / 11卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：159 / 159
页数：1
相关论文
共 50 条
  • [1] C-src tyrosine kinase activity is associated with tumor colonization in bone and lung in an animal model of human breast cancer metastasis
    Myoui, A
    Nishimura, R
    Williams, PJ
    Hiraga, T
    Tamura, D
    Michigami, T
    Mundy, GR
    Yoneda, T
    CANCER RESEARCH, 2003, 63 (16) : 5028 - 5033
  • [2] GROWTH AND OSTEOLYTIC BONE METASTASIS OF HUMAN BREAST-CANCER IS DEPENDENT ON THEIR SRC TYROSINE KINASE (TK) ACTIVITY
    NIEWOLNA, M
    NISHIMURA, R
    WILLIAMS, P
    DUNSTAN, C
    ADAMS, R
    SASAKI, A
    MUNDY, GR
    YONEDA, T
    JOURNAL OF BONE AND MINERAL RESEARCH, 1995, 10 : S177 - S177
  • [3] The tyrosine kinase Abl is required for Src-transforming activity in mouse fibroblasts and human breast cancer cells
    A Sirvent
    A Boureux
    V Simon
    C Leroy
    S Roche
    Oncogene, 2007, 26 : 7313 - 7323
  • [4] The tyrosine kinase Abl is required for Src-transforming activity in mouse fibroblasts and human breast cancer cells
    Sirvent, A.
    Boureux, A.
    Simon, V.
    Leroy, C.
    Roche, S.
    ONCOGENE, 2007, 26 (52) : 7313 - 7323
  • [5] Indirect costs associated with metastatic breast cancer.
    Wan, Yin
    Gao, Xin
    Mehta, Sonam
    Wang, Zhixiao
    Faria, Claudio
    Schwartzberg, Lee Steven
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (27)
  • [6] Lapatinib: A dual tyrosine kinase inhibitor for metastatic breast cancer
    Paul, Betsy
    Trovato, James A.
    Thompson, Jennifer
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2008, 65 (18) : 1703 - 1710
  • [7] Significance of Tyrosine Kinase Inhibitors in the Treatment of Metastatic Breast Cancer
    Mundhenke, Christoph
    Strauss, Alexander
    Schem, Christian
    BREAST CARE, 2009, 4 (06) : 373 - 378
  • [8] Inhibition of tyrosine kinase c-Src improves experimental breast cancer metastatic disease. Implication for therapy
    Rucci, N.
    Recchia, I.
    Angelucci, A.
    Alamanou, M.
    Del Fattore, A.
    Fortunati, D.
    Longo, M.
    Susa, M.
    Fabbro, D.
    Bologna, M.
    Teti, A.
    BONE, 2006, 39 (05) : S32 - S33
  • [9] Efficacy of HER2-targeted therapy in metastatic breast cancer. Monoclonal antibodies and tyrosine kinase inhibitors
    Nielsen, Dorte L.
    Kumler, Iben
    Palshof, Jesper A. E.
    Andersson, Michael
    BREAST, 2013, 22 (01): : 1 - 12
  • [10] Cost and burden of illness associated with metastatic breast cancer.
    Rao, S
    Gilden, D
    Kubisiak, J
    Harris, P
    BREAST CANCER RESEARCH AND TREATMENT, 2002, 76 : S137 - S137
12345